Rockefeller Capital Management
XLRN

Rockefeller Capital Management’s Acceleron Pharma XLRN Stock Holding History

Rockefeller Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29
Closed -$4K – 4117
2021
Q3 		$4K Hold
29
– – ﹤0.01% 3295
2021
Q2 		$3K Hold
29
– – ﹤0.01% 3211
2021
Q1 		$3K Buy
+29
New +$3.75K ﹤0.01% 3070

Rockefeller Capital Management's XLRN Position: Q4 2021 in Review

Rockefeller Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 29 shares — an estimated $4K sold.

Rockefeller Capital Management first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Rockefeller Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 29 Acceleron Pharma shares in Q4 2021, an estimated $4K.
  • Rockefeller Capital Management first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
  • Rockefeller Capital Management's Acceleron Pharma position peaked at $4K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Rockefeller Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.